ALX Oncology (ALXO) Short Interest Ratio & Short Volume $0.59 +0.07 (+13.24%) Closing price 04:00 PM EasternExtended Trading$0.57 -0.01 (-1.99%) As of 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALX Oncology Short Interest DataALX Oncology (ALXO) has a short interest of 4.39 million shares, representing 11.93% of the float (the number of shares available for trading by the public). This marks a -9.86% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.5, indicating that it would take 8.5 days of the average trading volume of 541,524 shares to cover all short positions.Current Short Interest4,390,000 sharesPrevious Short Interest4,870,000 sharesChange Vs. Previous Month-9.86%Dollar Volume Sold Short$2.05 millionShort Interest Ratio8.5 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares53,400,000 sharesFloat Size36,790,000 sharesShort Percent of Float11.93%Today's Trading Volume310,088 sharesAverage Trading Volume541,524 sharesToday's Volume Vs. Average57% Short Selling ALX Oncology? Sign up to receive the latest short interest report for ALX Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALXO Short Interest Over TimeALXO Days to Cover Over TimeALXO Percentage of Float Shorted Over Time ALX Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20254,390,000 shares $2.05 million -9.9%11.9%8.5 $0.47 6/30/20254,870,000 shares $2.02 million -10.5%14.4%9.2 $0.42 6/15/20255,440,000 shares $2.79 million -4.4%16.1%11.7 $0.51 5/31/20255,690,000 shares $2.76 million -2.4%16.8%10.9 $0.49 5/15/20255,830,000 shares $2.54 million -3.6%17.3%7.5 $0.44 4/30/20256,050,000 shares $3.27 million -1.5%17.8%7.6 $0.54 4/15/20256,140,000 shares $3.35 million -2.5%18.1%6.4 $0.55 3/31/20256,300,000 shares $3.92 million -1.4%18.5%6.2 $0.62 3/15/20256,390,000 shares $5.30 million +8.5%18.8%5.5 $0.83 2/28/20255,890,000 shares $6.48 million -8.7%17.3%4.6 $1.10 Get the Latest News and Ratings for ALXO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ALX Oncology and its competitors with MarketBeat's FREE daily newsletter. 2/15/20256,450,000 shares $7.10 million +7.7%19.2%6.1 $1.10 1/31/20255,990,000 shares $8.75 million -23.5%19.5%5.3 $1.46 1/15/20257,830,000 shares $12.76 million +3.0%25.4%6.9 $1.63 12/31/20247,600,000 shares $12.69 million -9.4%24.6%7.7 $1.67 12/15/20248,390,000 shares $12.17 million +17.0%24.4%9 $1.45 11/30/20247,170,000 shares $10.61 million -0.8%20.9%9.7 $1.48 11/15/20247,230,000 shares $9.33 million -7.8%21.1%10.6 $1.29 10/31/20247,840,000 shares $11.21 million -18.3%25.9%11.2 $1.43 10/15/20249,590,000 shares $14.96 million +2.9%31.7%8.8 $1.56 9/30/20249,320,000 shares $16.96 million -6.7%30.9%8.1 $1.82 9/15/20249,990,000 shares $22.18 million +0.1%33.1%8 $2.22 8/31/20249,980,000 shares $23.15 million +7.5%33.0%7.8 $2.32 8/15/20249,280,000 shares $24.59 million +2.2%31.0%6.7 $2.65 7/31/20249,080,000 shares $43.58 million +17.2%30.5%7.1 $4.80 7/15/20247,750,000 shares $62 million +40.7%26.0%9.1 $8.00 6/30/20245,510,000 shares $33.23 million +30.0%18.5%6.8 $6.03 6/15/20244,240,000 shares $34.13 million +45.7%14.2%5.8 $8.05 5/31/20242,910,000 shares $30.93 million -13.4%10.0%4.3 $10.63 5/15/20243,360,000 shares $50.47 million +6.3%11.6%6.2 $15.02 4/30/20243,160,000 shares $53.78 million -14.4%11.5%6.1 $17.02 4/15/20243,690,000 shares $47.56 million +18.3%13.5%8 $12.89 3/31/20243,120,000 shares $34.79 million +7.2%11.5%8 $11.15 3/15/20242,910,000 shares $32.88 million -16.4%10.7%7.7 $11.30 2/29/20243,480,000 shares $51.05 million -1.4%12.9%7.5 $14.67 2/15/20243,530,000 shares $59.27 million -2.5%13.1%7.8 $16.79 1/31/20243,620,000 shares $52.16 million -1.9%13.2%8 $14.41 1/15/20243,690,000 shares $52.91 million -2.1%13.5%8.2 $14.34 12/31/20233,770,000 shares $56.14 million -6.7%13.8%6.5 $14.89 12/15/20234,040,000 shares $54.74 million +3.1%14.8%2.9 $13.55 11/30/20233,920,000 shares $30.73 million +0.5%17.6%2.9 $7.84This Crypto Is Set to Explode in January (Ad)This Could Be the Most Important Crypto Law in History While the world celebrates Bitcoin becoming 2025’s top-performing asset, smart hedge funds are accumulating elsewhere. During the upcoming Crypto Hedge Fund Summit, you'll discover exactly which coins they’ve loaded up on before this historic vote.Click here to claim your free seat! 11/15/20233,900,000 shares $34.20 million +2.1%17.5%3.1 $8.77 10/31/20233,820,000 shares $27.50 million -2.1%20.8%3.2 $7.20 10/15/20233,900,000 shares $35.61 million +46.1%21.2%3.3 $9.13 9/30/20232,670,000 shares $12.82 million -11.9%14.5%2.4 $4.80 9/15/20233,030,000 shares $15.70 million -4.1%16.5%19.1 $5.18 8/31/20233,160,000 shares $13.46 million +5.0%17.2%16.6 $4.26 8/15/20233,010,000 shares $14.63 million +2.0%16.5%14.9 $4.86 7/31/20232,950,000 shares $18.02 million +1.0%16.5%14.1 $6.11 7/15/20232,920,000 shares $19.77 million -0.3%16.2%11.2 $6.77 6/30/20232,930,000 shares $22.00 million No Change16.2%9.9 $7.51 6/15/20232,930,000 shares $28.01 million No Change16.2%9.9 $9.56 5/31/20232,930,000 shares $19.54 million +2.1%16.1%9.3 $6.67 5/15/20232,870,000 shares $18.54 million -4.3%16.3%9.8 $6.46 4/30/20233,000,000 shares $17.82 million -23.9%17.0%10.6 $5.94 4/15/20233,940,000 shares $18.91 million +3.4%22.3%15.4 $4.80 3/31/20233,810,000 shares $17.22 million -4.3%21.7%16.9 $4.52 3/15/20233,980,000 shares $20.66 million +3.7%22.6%17.2 $5.19 2/28/20233,840,000 shares $25.42 million +5.2%21.9%22.1 $6.62 2/15/20233,650,000 shares $28.32 million -5.7%20.8%22.2 $7.76 1/31/20233,870,000 shares $35.99 million -4.4%22.1%22.1 $9.30 1/15/20234,050,000 shares $40.54 million -2.4%23.1%22.8 $10.01 12/30/20224,150,000 shares $46.77 million +0.2%23.7%24.3 $11.27 12/15/20224,140,000 shares $43.72 million -3.0%23.6%29.1 $10.56 11/30/20224,270,000 shares $47.40 million No Change24.3%29.3 $11.10 11/15/20224,270,000 shares $49.53 million -1.8%24.3%26.3 $11.60 10/31/20224,350,000 shares $52.81 million -1.1%23.9%25.5 $12.14 10/15/20224,400,000 shares $48.36 million -3.5%24.1%23.9 $10.99 9/30/20224,560,000 shares $43.64 million No Change25.0%22.6 $9.57 9/15/20224,560,000 shares $57.64 million +6.5%25.0%18.6 $12.64 8/31/20224,280,000 shares $55.64 million +11.8%23.5%11.8 $13.00 8/15/20223,830,000 shares $57.99 million -5.9%21.0%9.4 $15.14 7/31/20224,070,000 shares $39.40 million +4.1%20.5%8.9 $9.68 7/15/20223,910,000 shares $40.51 million -3.5%19.7%8.3 $10.36 6/30/20224,050,000 shares $32.76 million -12.3%20.4%8.7 $8.09 6/15/20224,620,000 shares $30.82 million +5.0%23.2%9.6 $6.67 5/31/20224,400,000 shares $33.75 million +10.6%22.1%11.5 $7.67 5/15/20223,980,000 shares $38.45 million +8.2%20.0%10.6 $9.66 4/30/20223,680,000 shares $47.03 million -6.4%17.9%9.5 $12.78 4/15/20223,930,000 shares $62.92 million -10.9%19.2%8.7 $16.01 3/31/20224,410,000 shares $74.53 million +7.3%21.6%8.7 $16.90 3/15/20224,110,000 shares $68.23 million +3.8%20.1%8.2 $16.60 2/28/20223,960,000 shares $71.76 million -9.2%19.4%6.9 $18.12 2/15/20224,360,000 shares $68.41 million +10.9%21.4%7.4 $15.69 1/31/20223,930,000 shares $62.88 million -11.7%19.6%6.8 $16.00 1/15/20224,450,000 shares $82.33 million +0.9%22.1%9.1 $18.50 12/31/20214,410,000 shares $94.77 million +16.4%21.9%10.6 $21.49 12/15/20213,790,000 shares $93.84 million +11.8%18.8%9.8 $24.76 11/30/20213,390,000 shares $109.02 million +0.6%17.0%11.7 $32.16 11/15/20213,370,000 shares $156.33 million +59.0%16.9%13.6 $46.39 10/29/20212,120,000 shares $118.80 million -8.6%10.8%8.6 $56.04The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again. 10/15/20212,320,000 shares $136.86 million +1.3%11.8%9.1 $58.99 9/30/20212,290,000 shares $169.14 million -6.9%11.6%8.7 $73.86 9/15/20212,460,000 shares $192.35 million +2.5%12.5%8.5 $78.19 8/31/20212,400,000 shares $168 million -2.0%12.2%8.3 $70.00 8/13/20212,450,000 shares $163.32 million -6.1%12.5%8.9 $66.66 7/30/20212,610,000 shares $152.84 million +25.5%14.0%10.6 $58.56 7/15/20212,080,000 shares $109.22 million +1.5%11.0%9.8 $52.51 6/30/20212,050,000 shares $112.09 million +1.5%10.9%9.9 $54.68 6/15/20212,020,000 shares $116.78 million -6.5%10.7%11 $57.81 5/28/20212,160,000 shares $122.17 million -5.3%11.5%9.4 $56.56 5/14/20212,280,000 shares $119.91 million +2.7%12.1%9.3 $52.59 4/30/20212,220,000 shares $159.09 million -4.7%12.0%8.7 $71.66 4/15/20212,330,000 shares $139.33 million +2.2%12.6%9.2 $59.80 3/31/20212,280,000 shares $155.77 million +76.7%12.6%9.2 $68.32 3/15/20211,290,000 shares $99.52 million +30.3%7.1%5.1 $77.15 2/26/2021990,000 shares $81.84 million +27.5%5.5%4.3 $82.67 2/12/2021776,800 shares $62.87 million -19.2%4.3%3.6 $80.93 1/29/2021961,400 shares $74.64 million -17.1%5.3%4.8 $77.64 1/15/20211,160,000 shares $96.29 million No Change6.4%6.4 $83.01 ALXO Short Interest - Frequently Asked Questions What is ALX Oncology's current short interest? Short interest is the volume of ALX Oncology shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 4,390,000 shares of ALXO short. 11.93% of ALX Oncology's shares are currently sold short. Learn More on ALX Oncology's current short interest. What is a good short interest ratio for ALX Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALXO shares currently have a short interest ratio of 8.0. Learn More on ALX Oncology's short interest ratio. Which institutional investors are shorting ALX Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ALX Oncology: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ALX Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.93% of ALX Oncology's floating shares are currently sold short. Is ALX Oncology's short interest increasing or decreasing? ALX Oncology saw a decrease in short interest in July. As of July 15th, there was short interest totaling 4,390,000 shares, a decrease of 9.9% from the previous total of 4,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ALX Oncology's float size? ALX Oncology currently has issued a total of 53,396,000 shares. Some of ALX Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ALX Oncology currently has a public float of 36,790,000 shares. How does ALX Oncology's short interest compare to its competitors? 11.93% of ALX Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ALX Oncology: Inhibikase Therapeutics, Inc. (4.13%), Protara Therapeutics, Inc. (7.49%), Anebulo Pharmaceuticals, Inc. (0.18%), Spero Therapeutics, Inc. (2.18%), Genelux Corporation (7.07%), Tenaya Therapeutics, Inc. (7.60%), Cardiol Therapeutics Inc. (2.19%), Coherus Oncology, Inc. (26.94%), ALT5 Sigma Corporation (6.62%), FitLife Brands Inc. (1.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short ALX Oncology stock? Short selling ALXO is an investing strategy that aims to generate trading profit from ALX Oncology as its price is falling. ALXO shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ALX Oncology? A short squeeze for ALX Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALXO, which in turn drives the price of the stock up even further. How often is ALX Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALXO, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies IKT Short Interest TARA Short Interest ANEB Short Interest SPRO Short Interest GNLX Short Interest TNYA Short Interest CRDL Short Interest CHRS Short Interest ALTS Short Interest FTLF Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALXO) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
